---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-031819"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:16:00.652494+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NRC Health Q3 2025: TRCV up 8% to $141.7M; Adj EBITDA +11% YoY to $10.9M

## Summary
- Revenue $34.6M (+2% QoQ); GAAP net income $4.1M (12% of revenue); Adj net income $5.0M (14% of revenue).
- GAAP EPS $0.18; adjusted EPS $0.23 on 22.1M diluted shares.
- Cash from operations $13.8M (+46% YoY), representing 40% of total revenue.
- Total Recurring Contract Value (TRCV) $141.7M, up 8% YoY; fourth consecutive quarterly growth.
- CEO Trent Green cited strong sales and improved customer retention as growth drivers.

## SEC filing metadata
- accession: 0001437749-25-031819
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/0001437749-25-031819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/nrc20251024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-031819
- JSON: https://secwatch.observer/filing/0001437749-25-031819.json
- Plain text: https://secwatch.observer/filing/0001437749-25-031819.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.